tiprankstipranks
Trending News
More News >
Vivos Therapeutics (VVOS)
NASDAQ:VVOS
US Market

Vivos Therapeutics (VVOS) Revenue

Compare
204 Followers

Vivos Therapeutics Revenue

Vivos Therapeutics had a revenue of 3.70M in the quarter ending Dec 31, 2024, with -4.20%. This bring the company's revenue in the last twelve months to 15.03M, Decreased 3.09%. In the fiscal year ending Dec 31, 2024, Vivos Therapeutics had annual revenue of 15.03M with 8.91% growth.
Revenue (ttm)
15.03M
Revenue Growth
9.47%
P/S Ratio
0.92
Revenue/Employee
$137,899
Employees
109
Market Cap
$13.78M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
15.03M1.23M+8.91%
Dec 31, 2023
13.80M-2.22M-13.87%
Dec 31, 2022
16.02M-861.00K-5.10%
Dec 31, 2021
16.89M3.82M+29.23%
Dec 31, 2020
13.07M1.67M+14.68%
Dec 31, 2019
11.39M7.60M+200.43%
Dec 31, 2018
3.79M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis